Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.
Reads0
Chats0
TLDR
Comparing the outcomes from three prospective multicenter studies investigating the use of CTC to monitor patients undergoing treatment for metastatic breast, colorectal, or prostate cancer is compared and the CTC definition used in these studies is reviewed.Abstract:
The increasing number of treatment options for patients with metastatic carcinomas has created a concomitant need for new methods to monitor their use. Ideally, these modalities would be noninvasive, be independent of treatment, and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor cells (CTCs) shed into the blood during metastasis may satisfy this need. We developed the CellSearch System to enumerate CTC from 7.5 mL of venous blood. In this review we compare the outcomes from three prospective multicenter studies investigating the use of CTC to monitor patients undergoing treatment for metastatic breast (MBC), colorectal (MCRC), or prostate cancer (MPC) and review the CTC definition used in these studies. Evaluation of CTC at anytime during the course of disease allows assessment of patient prognosis and is predictive of overall survival.read more
Citations
More filters
Journal ArticleDOI
Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer.
Anna S. Gerdtsson,Jana-Aletta Thiele,Stephanie N. Shishido,Serena Zheng,Randolph Schaffer,Kelly Bethel,Steven A. Curley,Heinz-Josef Lenz,Diana L. Hanna,Jorge Nieva,Anand Kolatkar,Carmen Ruiz,Mariam Rodriguez-Lee,Gerard J. Oakley,Jerry S.H. Lee,James W. Hicks,Peter Kuhn +16 more
TL;DR: The overall findings demonstrate that liquid biopsy cells can be informative biomarkers in the mCRC setting by introducing tumor touch preparations to the High-Definition Single Cell Analysis workflow for high-resolution cytomorphometric characterization of metastatic colorectal cancer.
Journal ArticleDOI
Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization.
Evan N. Cohen,Gitanjali Jayachandran,Max R. Hardy,Ananya M. Venkata Subramanian,Xiangtian Meng,James M. Reuben +5 more
TL;DR: An antibody-agnostic platform, the Parsortix PR1 system, which enriches CTCs based on cell size and membrane deformability and may be amenable to transition into routine clinical workflows is employed.
Journal Article
Circulating Tumour Cells in Patients with Malignant Lung Tumors Undergoing Radio-frequency Ablation.
TL;DR: This study demonstrates that the manipulation and ablative procedure of lung tumors leads to immediate dissemination of tumor cells, the effects of which are unknown and require further investigation.
Journal ArticleDOI
Recognition and sensitive detection of CTCs using a controllable label-free electrochemical cytosensor
TL;DR: The experimental results indicate that the proposed controllable electrochemical cytosensor is highly-sensitive, and convenient for clinical detection of breast CTCs.
Journal ArticleDOI
State-of-Art Bio-Assay Systems and Electrochemical Approaches for Nanotoxicity Assessment.
TL;DR: This review attempted to provide a detailed information on the recent advancements made in development of bioassay models and systems for assessing the nanotoxicology by focusing on multiple mechanisms involved in the cell toxicity and electrochemical probing of the biological interactions.
References
More filters
Journal ArticleDOI
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
TL;DR: It is now known that the potential of a tumour cell to metastasize depends on its interactions with the homeostatic factors that promote tumour-cell growth, survival, angiogenesis, invasion and metastasis.
Journal ArticleDOI
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Massimo Cristofanilli,G. Thomas Budd,Matthew J. Ellis,Alison Stopeck,Jeri Matera,M. Craig Miller,James M. Reuben,Gerald V. Doyle,W. Jeffrey Allard,Leon W.M.M. Terstappen,Daniel F. Hayes +10 more
TL;DR: The number of circulating tumor cells before treatment is an independent predictor of progression-free survival and overall survival in patients with metastatic breast cancer.
Journal ArticleDOI
Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Sunitha Nagrath,Lecia V. Sequist,Shyamala Maheswaran,Daphne W. Bell,Daphne W. Bell,Daniel Irimia,Lindsey Ulkus,Matthew R. Smith,Eunice L. Kwak,Subba R. Digumarthy,Alona Muzikansky,Paula D. Ryan,Ulysses J. Balis,Ulysses J. Balis,Ronald G. Tompkins,Daniel A. Haber,Mehmet Toner +16 more
TL;DR: The CTC-chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 samples, with a range of 5–1,281CTCs per ml and approximately 50% purity.
Journal ArticleDOI
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
W. Jeffrey Allard,Jeri Matera,M. Craig Miller,Madeline Repollet,Mark Connelly,Chandra Rao,Arjan G.J. Tibbe,Jonathan W. Uhr,Leon W.M.M. Terstappen +8 more
TL;DR: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs, which are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.
Journal ArticleDOI
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono,Howard I. Scher,R. Bruce Montgomery,Chris Parker,M. Craig Miller,H. Tissing,Gerald V. Doyle,Leon W.W.M. Terstappen,Kenneth J. Pienta,Derek Raghavan +9 more
TL;DR: CTC are the most accurate and independent predictor of OS in CRPC, and this data led to Food and Drug Administration clearance of this assay for the evaluation of CRPC.